The Inflation Reduction Act (IRA) of 2022 mandates price negotiations for certain drugs under Medicare, shortening the exclusivity period historically used to recoup research and development ...
Opinions expressed by Digital Journal contributors are their own. Bringing a new biologic drug from concept to clinic is a complex journey fraught with technical and regulatory hurdles. For ...
WASHINGTON — Early-stage drug development worldwide has nearly doubled over the past decade and shifted from a U.S.-dominated model to a dual hub centered in the United States and China, according to ...
The goal of this collaborative was to examine the contributing factors towards the failure of late-stage clinical product development and develop key considerations for stakeholders to improve the ...
Ace Therapeutics is highlighting its comprehensive services for in vivo cardiovascular drug evaluation, designed to ...
One in four new drugs approved in the US between January 2008 and December 2017 received direct funding from public resources for late stage research or through spin-off companies created from public ...
A comprehensive scientific review outlines how lyophilization, formulation optimization, and advanced process analytics ...
Dublin, Oct. 22, 2025 (GLOBE NEWSWIRE) -- The "Batten Disease - Pipeline Insight, 2025" has been added to ResearchAndMarkets.com's offering. The "Batten Disease - Pipeline Insight, 2025" report offers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results